ArticleClinical cancer research : an official journal of the American Association for Cancer Research2014

MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitro.

Trevor E Angell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.